Sandra Nino-Siddens

Sandra Nino-Siddens, PharmD has extensive experience in the pharmaceutical industry. Sandra is currently the Vice President Global Regulatory Affairs at Ultragenyx Pharmaceutical Inc. Prior to this role, they served as the Senior Group Director and Global Regulatory Lead for Ophthalmology at Genentech. Sandra also held the position of Group Director, Regulatory Affairs Oncology at Genentech. Before their time at Genentech, they were the Head of Clinical Regulatory Affairs at Geron Corporation. Sandra has also worked as the Head of Regulatory Affairs Americas at ICON plc and as the Head of Regulatory Affairs at Spectrum Pharmaceuticals, Inc. Additionally, they have experience in regulatory affairs at Pfizer (formerly AGOURON Pharmaceuticals). Throughout their career, Sandra has successfully managed drug development, led regulatory affairs activities, and interacted with health authorities. Sandra has a strong background in oncology and has submitted several successful regulatory submissions.

Sandra Nino-Siddens, PharmD earned their Pharm.D. degree in Pharmacy from Paris-Sud University (Paris XI) in 1998. Sandra also obtained a Master's degree in International Drug Development and Registration from the same university. Further education history details are not provided.